Discount Agreement for Hydroxycarbamide (FTA) with DAK-Gesundheit
DAK-Gesundheit is entering into non-exclusive discount agreements for Hydroxycarbamide (FTA) to ensure supply until August 1, 2028. This allows all interested pharmaceutical companies to join under attractive conditions.
CONTRACTING AUTHORITY
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
1083 days remaining(LOT-0001)
Published